These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7084938)

  • 1. Nuclear feulgen DNA content and nuclear size in human breast carcinoma.
    Fosså SD; Marton PF; Knudsen OS; Kaalhus O; Børmer O; Vaage S
    Hum Pathol; 1982 Jul; 13(7):626-30. PubMed ID: 7084938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear DNA content of human breast carcinoma. Associations with clinical stage, axillary lymph node status, estrogen receptor status and outcome.
    Berryman IL; Harvey JM; Sterrett GF; Papadimitriou JM
    Anal Quant Cytol Histol; 1987 Oct; 9(5):429-34. PubMed ID: 3675802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytophotometric measurements of nuclear DNA content values in human breast lesions.
    Enchev VG; Dobreva PV
    Arch Geschwulstforsch; 1987; 57(1):31-7. PubMed ID: 3566463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA in situ sensitivity to denaturation as a marker of human breast tumors.
    Kunicka JE; Olszewski W; Rosen PP; Kimmel M; Melamed MR; Darzynkiewicz Z
    Cancer Res; 1989 Nov; 49(22):6347-51. PubMed ID: 2804980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feulgen DNA cytophotometry in histologic sections of mammary neoplasms.
    Berryman I; Sterrett GF; Papadimitriou JM
    Anal Quant Cytol; 1984 Mar; 6(1):19-23. PubMed ID: 6732070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nuclear DNA content of lobular neoplasia of the mammary gland.
    Zippel HH; Kunze WP
    Arch Gynakol; 1977 May; 222(3):265-74. PubMed ID: 578099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feulgen-DNA-cytophotometry on mammary tumor cells from aspiration biopsy smears.
    Boquoi E; Krebs S; Kreuzer G
    Acta Cytol; 1975; 19(4):326-9. PubMed ID: 51568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative FISH analysis on interphase nuclei may improve diagnosis of DNA diploid breast cancers.
    Truong K; Vielh P; Guilly MN; Klijanienko J; Sastre-Garau X; Soussaline F; Dutrillaux B; Malfoy B
    Diagn Cytopathol; 2002 Apr; 26(4):213-6. PubMed ID: 11933265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of nuclear grade and DNA cytometry in breast carcinoma aspirates to histologic grade in excised cancers.
    Davey DD; Banks ER; Jennings D; Powell DE
    Am J Clin Pathol; 1993 Jun; 99(6):708-13. PubMed ID: 8322705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA aneuploidy and cell proliferation in breast tumors.
    Christov K; Milev A; Todorov V
    Cancer; 1989 Aug; 64(3):673-9. PubMed ID: 2743262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic relevance of nuclear Feulgen DNA in transitional cell carcinoma of the urinary bladder. A long-term follow-up study.
    Fosså SD; Kaalhus O
    Eur Urol; 1985; 11(6):418-21. PubMed ID: 2417858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesions.
    Spyratos F; Briffod M; Gentile A; Brunet M; Brault C; Desplaces A
    Anal Quant Cytol Histol; 1987 Dec; 9(6):485-94. PubMed ID: 3435626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA flow cytometry in primary breast carcinoma.
    Fosså SD; Thorud E; Shoaib MC; Pettersen EO; Høie J; Knudsen OS
    Acta Pathol Microbiol Immunol Scand A; 1984 Nov; 92(6):475-80. PubMed ID: 6516845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear DNA content of fine needle aspirates of invasive ductal carcinomas of the breast.
    Sarker S; Spigelman A; Walker M; Coleman D
    Anal Cell Pathol; 1997; 13(1):1-8. PubMed ID: 9154308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure and mixed mucinous breast carcinomas: DNA stemline and prognosis.
    Toikkanen S; Eerola E; Ekfors TO
    J Clin Pathol; 1988 Mar; 41(3):300-3. PubMed ID: 2834422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear DNA and endocrine activity in carcinomas of the breast.
    Wilander E; Lindgren A; Nister M; Ponten J
    Cancer; 1984 Sep; 54(6):1016-8. PubMed ID: 6467128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear deoxyribonucleic acid heterogeneity of ovarian borderline malignant serous tumors.
    Fu YS; Ro J; Reagan JW; Hall TL; Berek J
    Obstet Gynecol; 1986 Apr; 67(4):478-82. PubMed ID: 3960418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of DNA stemline and cell kinetics between primary breast cancer and its lymph node metastasis.
    Chang DB; Yang PC; Chang KJ; Luh KT; Kuo SH
    Anal Quant Cytol Histol; 1993 Feb; 15(1):32-8. PubMed ID: 8385953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear DNA content in breast carcinomas with neuroendocrine differentiation.
    Nesland JM; Pettersen EO; Fosså SD; Høie J; Johannessen JV
    J Pathol; 1986 Nov; 150(3):181-5. PubMed ID: 3027292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal neoplasms of the breast: a comparative flow cytometric study.
    El-Naggar AK; Mackay B; Sneige N; Batsakis JG
    J Surg Oncol; 1990 Jul; 44(3):151-6. PubMed ID: 2164618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.